Publications by authors named "Stan Gertler"

Claim this Profile
D
Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial.
Susan J Robertson, Mohammed F K Ibrahim, Carol Stober, John Hilton, Zuzana Kos, Stan Gertler

J Eval Clin Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.
Mohammed F K Ibrahim, John Hilton, Sasha Mazzarello, Dean Fergusson, Brian Hutton, Stan Gertler

Breast Cancer Res Treat· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial.
Mark Clemons, Nathaniel Bouganim, Stephanie Smith, Sasha Mazzarello, Lisa Vandermeer, Stan Gertler

JAMA Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.
Christina L Addison, Nathaniel Bouganim, John Hilton, Lisa Vandermeer, Susan Dent, Stan Gertler

Breast Cancer Res Treat· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.
Kathleen Beusterien, Jessica Grinspan, Iryna Kuchuk, Sasha Mazzarello, Susan Dent, Stan Gertler

Oncologist· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.
Dominique Frechette, Lise Paquet, Shailendra Verma, Mark Clemons, Paul Wheatley-Price, Stan Z Gertler

Breast Cancer Res Treat· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer.
Susan F Dent, Stan Gertler, Shailendra Verma, Roanne Segal, Vince Young

Cancer Chemother Pharmacol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of SarCNU in malignant glioma: unexpected pulmonary toxicity with a novel nitrosourea: a phase II trial of the national cancer institute of canada clinical trials group.
Marc Webster, Gregory Cairncross, Stan Gertler, James Perry, Nancy Wainman

Invest New Drugs· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group.
Sarah Kirby, Stan Z Gertler, Warren Mason, Christopher Watling, Peter Forsyth

Neuro Oncol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.
John F R Robertson, Bjorn Erikstein, Kent C Osborne, John Pippen, Steven E Come, Stan Gertler

Clin Pharmacokinet· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories.
Karen A Gelmon, John Mackey, Shailendra Verma, Stan Z Gertler, Nicholas Bangemann

Clin Breast Cancer· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma.
Karl Bélanger, David MacDonald, Gregory Cairncross, Stan Gertler, Peter Forsyth

Invest New Drugs· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.
John F R Robertson, C Kent Osborne, Anthony Howell, Stephen E Jones, Louis Mauriac, Stan Gertler

Cancer· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis